Amicus Therapeutics Announces Settlement of Galafold® ( migalastat ) Patent Litigation with Teva

Yesterday

Company Grants Teva a License to Market Generic Galafold® Beginning in January 2037 Company Grants Teva a License to Market Generic Galafold® Beginning in January ...

Ticker	Sentiment	Impact
FOLD	Bullish	32 %